IMMU-11. PRECLINICAL HIGH-RISK PEDIATRIC BRAIN TUMOR MODELS FOR IMMUNOTHERAPY: HURDLES AND THE WAY FORWARD

Despite recent therapeutic advancements in the treatment of pediatric brain tumors, high-risk brain tumors (pHRBT) remain the leading cause of cancer-related deaths in children. In recent years, immunotherapy has become a viable treatment option for several cancers including brain tumors. However, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Deepak, Morris, Shelli, Popovsk, Dean, Bondoc, Andrew, Kumar, Shiva Senthil, Rutka, James, Huang, Annie, Olson, Jim, Fouladi, Maryam, Drissi, Rachid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Immunology/Immunotherapy - IMMU
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260156/
http://dx.doi.org/10.1093/neuonc/noad073.198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260156/
http://dx.doi.org/10.1093/neuonc/noad073.198

Ejemplares similares